# Australian retail and medical technology valuations

> Live situation record from CLSTR: https://clstr.news/situations/australian-retail-and-medical-technology-valuations
> Updated: 2026-08-19T19:54:55.000Z. Sources: 2. Developments: 2.

Australian retail and medical technology companies, specifically Woolworths Group, Coles Group, and Cochlear Ltd, are undergoing investor valuation reviews.

Woolworths Group reported a 30% share price increase over a 12-month period, supported by a 5.9% rise in Australian food sales and a 20% increase in online sales. The company maintains a dominant 35% share of the Australian grocery market. 

As market scrutiny continues, Coles Group is being evaluated based on its ability to achieve projected earnings growth through investments in automated distribution. Simultaneously, Cochlear Ltd has experienced a significant share price decline since the start of 2025, leading analysts to view the medical technology firm as a potential interest for growth-focused investors.

## Timeline

### 2026-08-19: Coles, Woolworths, and Cochlear valuations under review

Analysis of Australian ASX-listed companies Coles, Woolworths, and Cochlear highlights varying valuation trends across the retail and medical technology sectors.

2 sources. https://clstr.news/cluster/coles-woolworths-and-cochlear-valuations-under-review

### 2026-07-29: Woolworths Group shares jump 30% as analysts assess valuation and growth

Woolworths shares rose 30% to a 52‑week high, driven by sales growth and supply‑chain upgrades; analysts compare its valuation and dividend yield to Cochlear, whose shares have fallen 54% despite global market‑

2 sources. https://clstr.news/cluster/woolworths-group-shares-jump-30-as-analysts-assess-valuation-and-growth

---
Cite as: Australian retail and medical technology valuations. CLSTR, https://clstr.news/situations/australian-retail-and-medical-technology-valuations